Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer's Disease (vol 26, pg 522, 2008)

被引：1
|
作者：
Verwey, Nicolaas A.
机构：
来源：
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS | 2009年 / 27卷 / 06期
关键词：
D O I：
10.1159/000228931
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [1] Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer's Disease
    Verwey, Nicolaas A.
    Schuitemaker, Alie
    van der Flier, Wiesje M.
    Mulder, Sandra D.
    Mulder, Cees
    Hack, C. Erik
    Scheltens, Philip
    Blankenstein, Marinus A.
    Veerhuis, Robert
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 26 (06) : 522 - 527
  • [2] A BIOMARKER CANDIDATE FOR ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT
    Yun, S. M.
    Jang, B. G.
    Ahn, K.
    Chae, S.
    Kim, D. K.
    Park, M. H.
    Jo, S. A.
    Koh, Y. H.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 66 - 66
  • [3] Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment (vol 121, pg 105, 2008)
    Lee, Kang Soo
    Chung, Ji Hyung
    Lee, Kyung Hye
    Shin, Min-Jeong
    Oh, Byoung Hoon
    Hong, Chang Hyung
    IMMUNOLOGY LETTERS, 2009, 123 (01) : 96 - 96
  • [4] Amyloid PET and MRI in Alzheimer's Disease and Mild Cognitive Impairment
    Dimou, E.
    Booij, J.
    Rodrigues, M.
    Prosch, H.
    Attems, J.
    Knoll, P.
    Zajicek, B.
    Dudczak, R.
    Mostbeck, G.
    Kuntner, C.
    Langer, O.
    Bruecke, T.
    Mirzaei, S.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 312 - 319
  • [5] Brain Glutathione Levels - A Novel Biomarker for Mild Cognitive Impairment and Alzheimer's Disease (vol 78, pg 702, 2015)
    Mandal
    BIOLOGICAL PSYCHIATRY, 2016, 79 (01) : 71 - 71
  • [6] Entorhinal cortex: a good biomarker of mild cognitive impairment and mild Alzheimer's disease
    Zhou, Mengxi
    Zhang, Feng
    Zhao, Li
    Qian, Jin
    Dong, Chunbo
    REVIEWS IN THE NEUROSCIENCES, 2016, 27 (02) : 185 - 195
  • [7] Serum amyloid P component level in Alzheimer's disease
    Nishiyama, E
    Iwamoto, N
    Kimura, M
    Arai, H
    DEMENTIA, 1996, 7 (05): : 256 - 259
  • [8] A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology
    Abe, Koji
    Shang, Jinwei
    Shi, Xiaowen
    Yamas, Toru hita
    Hishikawa, Nozomi
    Takemoto, Mami
    Morihara, Ryuta
    Nakano, Yumiko
    Ohta, Yasuyuki
    Deguchi, Kentaro
    Ikeda, Masaki
    Ikeda, Yoshio
    Okamoto, Koichi
    Shoji, Mikio
    Takatama, Masamitsu
    Kojo, Motohisa
    Kuroda, Takeshi
    Ono, Kenjiro
    Kimura, Noriyuki
    Matsubara, Etsuro
    Osakada, Yosuke
    Wakutani, Yosuke
    Takao, Yoshiki
    Higashi, Yasuto
    Asada, Kyoichi
    Senga, Takehito
    Lee, Liang-Ja
    Tanaka, Kenji
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (01) : 217 - 227
  • [9] Molecular imaging of brain amyloid in mild cognitive impairment and Alzheimer's disease
    Paul M Matthews
    Nature Clinical Practice Neurology, 2007, 3 : 366 - 367
  • [10] Plasma lipoprotein β-amyloid in subjects with Alzheimer's disease or mild cognitive impairment
    Mamo, J. C. L.
    Jian, L.
    James, A. P.
    Flicker, L.
    Esselmann, H.
    Wiltfang, J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 395 - 403
12345